New bedside test could help doctors fine-tune antibiotics in real time
NCT ID NCT07666230
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study will test a new, fast method to measure levels of beta-lactam antibiotics in the blood of intensive care patients. Researchers will compare the new method with standard lab tests using daily blood samples from 200 patients. The goal is to develop a point-of-care tool that allows doctors to quickly adjust antibiotic doses for better treatment.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- beta-lactam antibiotics
- What this could lead to
- If successful, this could enable doctors to quickly adjust antibiotic doses for ICU patients, improving treatment effectiveness.
- What could go wrong
- This is an early-stage method validation study, not a treatment trial. The new test may not be accurate enough or practical for routine use.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BACTERIAL INFECTIONS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a simple blood test curb antibiotic overuse in sick kids?
- New drug CTX-187 takes aim at stubborn bacterial infections
- Can smarter antibiotic choices curb superbugs in liver disease?
- Vaccine Follow-Up: how long does protection last in babies?
- New antibiotic vabomere tested in kids for first time
- Could personalized antibiotic dosing save lives in liver cirrhosis?